SGLT2 Inhibitors Should Be Considered for All Patients With Heart Failure ∗
Ahmad T, Desai NR, Velazquez EJ. SGLT2 Inhibitors Should Be Considered for All Patients With Heart Failure ∗. Journal Of The American College Of Cardiology 2022, 80: 1311-1313. PMID: 36041913, DOI: 10.1016/j.jacc.2022.08.005.Peer-Reviewed Original ResearchDiabetes Mellitus, Type 2GlucoseHeart FailureHumansSodium-Glucose Transporter 2Sodium-Glucose Transporter 2 InhibitorsStroke Volume